ArticleFrontiers in oncology2026

Interim efficacy and preliminary survival outcomes of polatuzumab vedotin in combination for diffuse large B-cell lymphoma: a retrospective real-world study.

Songshen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.